Ferroptosis contributes to isoflurane-induced neurotoxicity and learning and memory impairment

Pengfei Liu1,2, Jing Yuan1, Yetong Feng3

  • 1Ambulatory Surgical Center, The Second Clinical Medical College, Jinan University (Shenzhen People's Hospital), 518020, Shenzhen, China.

Cell Death Discovery
|April 8, 2021
PubMed

Insights

Isoflurane anesthesia triggers ferroptosis, a cell death pathway, in the mouse hippocampus. Inhibiting ferroptosis or activating mitochondria protects against isoflurane-induced memory deficits.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pharmacology

Background:

  • Ferroptosis is a distinct form of programmed cell death.
  • Isoflurane, a common anesthetic, causes in vitro neurotoxicity linked to ferroptosis.
  • The in vivo role of ferroptosis in isoflurane-induced neurotoxicity and memory impairment is not well understood.

Purpose of the Study:

  • To investigate the relationship between ferroptosis and isoflurane-induced learning and memory deficits in a mouse model.
  • To explore potential therapeutic strategies targeting ferroptosis for isoflurane-induced neurotoxicity.

Main Methods:

  • Mice were exposed to varying doses and durations of isoflurane.
  • Ferroptosis markers and mitochondrial activity (cytochrome c oxidase/Complex IV) in the hippocampus were assessed.
  • The effects of ferrostatin-1 (ferroptosis inhibitor) and dimethyl fumarate (mitochondria activator) were evaluated.

Main Results:

  • Isoflurane induced ferroptosis in the hippocampus in a dose- and time-dependent manner.
  • Isoflurane increased mitochondrial electron transport chain (ETC) Complex IV activity, potentially exacerbating cysteine deprivation-induced ferroptosis.
  • Ferrostatin-1 and dimethyl fumarate treatment rescued isoflurane-induced ferroptosis and ameliorated learning and memory impairment.

Conclusions:

  • Ferroptosis is closely associated with isoflurane-induced neurotoxicity and memory impairment in vivo.
  • Mitochondrial dysfunction plays a role in isoflurane-induced ferroptosis.
  • Targeting ferroptosis or activating mitochondria offers a promising therapeutic approach for mitigating isoflurane's adverse cognitive effects.